The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time

BACKGROUND: Established therapies for managing kidney dysfunction such as kidney dialysis and transplantation are limited due to the shortage of compatible donated organs and high costs. Stem cell-based therapies are currently under investigation as an alternative treatment option. As amniotic fluid...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Md Shaifur, Spitzhorn, Lucas-Sebastian, Wruck, Wasco, Hagenbeck, Carsten, Balan, Percy, Graffmann, Nina, Bohndorf, Martina, Ncube, Audrey, Guillot, Pascale V., Fehm, Tanja, Adjaye, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918774/
https://www.ncbi.nlm.nih.gov/pubmed/29695308
http://dx.doi.org/10.1186/s13287-018-0864-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918774/
https://www.ncbi.nlm.nih.gov/pubmed/29695308
http://dx.doi.org/10.1186/s13287-018-0864-7

Ejemplares similares